发明名称 |
TRITOQUALINE FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS |
摘要 |
The present invention relates to the use of a histamine H4 agonist molecule, the enantiomers of the (AMINO-7 TRIETHOXY-4,5,6 OXO-1 DIHYDRO-1,3 ISOBENZOFURANNYL-3)-1METHOXY-8 METHYL-2 METHYLENEDIOXY-6,7 TETRAHYDRO-,2,3,4 ISOQUINOLINE or tritoqualine for the treatment of respiratory impairment caused by cystic fibrosis and the reduction and prevention of bronchial superinfections. |
申请公布号 |
US2015133666(A1) |
申请公布日期 |
2015.05.14 |
申请号 |
US201314403484 |
申请日期 |
2013.05.21 |
申请人 |
Terrasse Gaetan |
发明人 |
Terrasse Gaetan |
分类号 |
A61K31/4355 |
主分类号 |
A61K31/4355 |
代理机构 |
|
代理人 |
|
主权项 |
1. A substance having an agonist activity on the histamine H4 receptor for the treatment of cystic fibrosis, characterized in that it comprises an isomer or a mixture of isomers of 7-Amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl) phthalide, or tritoqualine. |
地址 |
Montceau Les Mines FR |